Combination Immunotherapy: An Emerging Paradigm in Cancer Therapeutics

被引:0
|
作者
Wang, Daniel Y. [1 ]
Sosman, Jeffrey A. [2 ]
Johnson, Douglas B. [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN 37235 USA
[2] Vanderbilt Univ, Med Ctr, Melanoma & Tumor Immunotherapy Program, Nashville, TN 37235 USA
来源
ONCOLOGY-NEW YORK | 2015年 / 29卷 / 12期
关键词
PD-1; BLOCKADE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1005 / 1006
页数:2
相关论文
共 50 条
  • [1] Nanocrystals: an emerging paradigm for cancer therapeutics
    Ayush Patel
    Krishi Patel
    Viral Patel
    Mithun Singh Rajput
    Ravish Patel
    Amarjitsing Rajput
    Future Journal of Pharmaceutical Sciences, 10
  • [2] Nanocrystals: an emerging paradigm for cancer therapeutics
    Patel, Ayush
    Patel, Krishi
    Patel, Viral
    Rajput, Mithun Singh
    Patel, Ravish
    Rajput, Amarjitsing
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 10 (01)
  • [3] Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics
    McCloskey, Curtis W.
    Rodriguez, Galaxia M.
    Galpin, Kristianne J. C.
    Vanderhyden, Barbara C.
    CANCERS, 2018, 10 (08)
  • [4] Combination of chemotherapy and immunotherapy for cancer: a paradigm revisited
    Gabrilovich, Dmitry I.
    LANCET ONCOLOGY, 2007, 8 (01): : 2 - 3
  • [5] Radiation with immunotherapy: an emerging combination for cancer treatment
    Jiang, Wen
    Tang, Chad
    Chang, Joe Y.
    JOURNAL OF RADIATION ONCOLOGY, 2015, 4 (04) : 331 - 338
  • [6] Immunotherapy for HNSCC: an emerging paradigm?
    Guigay, J.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S190 - S191
  • [7] Emerging strategies for combination checkpoint modulators in cancer immunotherapy
    Popovic, Aleksandra
    Jaffee, Elizabeth M.
    Zaidi, Neeha
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (08): : 3209 - 3218
  • [8] mRNA therapeutics in cancer immunotherapy
    Beck, Jan D.
    Reidenbach, Daniel
    Salomon, Nadja
    Sahin, Ugur
    Tureci, Ozlem
    Vormehr, Mathias
    Kranz, Lena M.
    MOLECULAR CANCER, 2021, 20 (01)
  • [9] mRNA therapeutics in cancer immunotherapy
    Jan D. Beck
    Daniel Reidenbach
    Nadja Salomon
    Ugur Sahin
    Özlem Türeci
    Mathias Vormehr
    Lena M. Kranz
    Molecular Cancer, 20
  • [10] The emerging role of exosome and microvesicle- (EMV-) based cancer therapeutics and immunotherapy
    Moore, Colin
    Kosgodage, Uchini
    Lange, Sigrun
    Inal, Jameel M.
    INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (03) : 428 - 436